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adulthood. We found that the phenotype of myocardial B cells changed dynamically during development. While neonatal
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spleen showed that the dynamic changes in B cell subpopulations observed in the heart during development mirrored
changes observed in the other organs. Single cell RNA sequencing (scRNAseq) analysis of B cells showed that
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These findings broaden our understanding of the biology of myocardial-associated B cells and suggest that current
models of the dynamics of naive B cells during development are incomplete.
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Introduction
The immune system plays a critical role in the context of  myocardial homeostasis and adaptation to injury 
(1), and it is therefore critical to understand the biology of  the myocardial leukocyte pool. Surprisingly, 
while B cells are the second most prevalent leukocyte population in the naive murine heart (2, 3) and play 
important roles in the context of  cardiac adaptation to injury (4–9), little is known with respect to the basic 
aspects B cell biology in the heart. Current models of  B cell biology posit that, in the absence of  tissue 
inflammation, B cells continuously circulate through blood and lymphatic vessels, moving between prima-
ry and secondary lymphoid tissue without accumulating in peripheral tissue (10–12).
However, this prevailing view has been challenged by the notion that myocardial-associated B cells 
are a subset of  circulating B cells. We have recently identified a population of  intravascular myocardial- 
associated B cells that remain in close approximation with the microvascular endothelial cells in the heart, 
in the absence of  discernible tissue injury, and express a transcriptional profile that is distinct from that of  
circulating peripheral B cells (13). Our initial observations were limited to characterizing B cell biology in 
the naive adult mouse heart and did not address more fundamental questions regarding the characteris-
tics of  B cells in the embryonic, neonatal, and adult heart — nor did they address whether myocardial B 
cells shared common biological profiles with B cells in other organs. In the present study, we characterize 
myocardial B cells from embryonic to early adult life and compare these changes with those occurring in 
B cells in the blood, spleen, liver, and lung using a combination of  flow cytometry, immunofluorescence, 
intravital microscopy, and single cell RNA sequencing (scRNAseq). Here, we show for the first time to our 
knowledge that myocardial-associated B cells are in equilibrium with splenic B cells throughout life and are 
representative of  a much larger population of  B cells that are associated with the lung and liver.
Results
Characterization of  myocardial-associated B cells from embryonic to adult stage. We have previously described 
(5, 13) 3 subsets of  CD19+ B cells in the murine heart: (a) CD11b+CD5+IgMhi, consistent with B1a cells; 
The naive heart harbors a population of intravascular B cells that make close contact with the 
cardiac microvasculature. However, the timing of their appearance and their organ specificity remain 
unknown. To address this knowledge gap, we performed a systematic analysis of B cells isolated 
from the myocardium and other organs, from embryonic life to adulthood. We found that the 
phenotype of myocardial B cells changed dynamically during development. While neonatal heart B 
cells were mostly CD11b+ and CD11b– CD21–CD23–, adult B cells were predominantly CD11b–CD21+CD23+. 
Histological analysis and intravital microscopy of lung and liver showed that organ-associated B 
cells in contact with the microvascular endothelium were not specific to the heart. Flow cytometric 
analysis of perfused hearts, livers, lungs, and spleen showed that the dynamic changes in B cell 
subpopulations observed in the heart during development mirrored changes observed in the other 
organs. Single cell RNA sequencing (scRNAseq) analysis of B cells showed that myocardial B cells 
were part of a larger population of organ-associated B cells that had a distinct transcriptional profile. 
These findings broaden our understanding of the biology of myocardial-associated B cells and 
suggest that current models of the dynamics of naive B cells during development are incomplete. 
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(b) CD11b+CD5–IgMhi, consistent with B1b cells; and (c) CD11b– B2 cells. By further refining our tissue 
digestion protocol, we were able to reliably identify 2 additional CD markers frequently used to classify 
murine B cells, namely CD21 and CD23 (14) (Supplemental Figure 1; for details, see Methods; sup-
plemental material available online with this article; https://doi.org/10.1172/jci.insight.139377DS1). 
Using this optimized protocol, we identified 2 additional CD19+CD11b– myocardial B cell subsets: (a) 
CD21+CD23+ and (b) CD21–CD23–, which are characteristic of  multiple subtypes of  B2 cells (full gating 
strategy and myocardial subsets are shown in Supplemental Figure 2).
In order to study the characteristics of  B cells in the heart, we analyzed freshly isolated hearts of  naive 
WT mice from E13.5 to 10 weeks of  age. We found that B cells were present in the heart at E13.5 and that 
the relative prevalence of  myocardial B cell subsets changed dynamically during development and early 
postnatal life (Figure 1, A–C). CD19+CD11b+IgMhiCD5+ cells were more abundant in the embryonic 
hearts (E13.5–E15.5). Their prevalence decreased rapidly by the time of  birth (P1) but increased again in 
early neonatal life (peak at P7) (Figure 1A and Supplemental Table 1). This increase was not sustained, 
however, and this subgroup of  B cells constituted only a small fraction of  B cells in the adult heart (Figure 
1 and Supplemental Table 1). At birth, most myocardial B cells were CD19+CD11b–CD21–CD23–. The 
prevalence of  this subpopulation gradually decreased as the mice aged, whereas the prevalence of  the 
CD19+CD11b–CD21+CD23+ subset increased (Figure 1 and Supplemental Table 1). The expression of  
IgM and IgD in CD11b– B cells also changed dynamically during development (Supplemental Figure 3), 
with IgMhiIgDlo subsets of  B cells prominent in embryonic and P1 through P14 hearts, and IgMhiIgDhi and 
IgMloIgDhi B cells prominent during late postnatal (P21) and adult hearts.
In order to gain further insight into the identity of  the various myocardial B cells subsets, we per-
formed scRNAseq of  neonatal (2 weeks) and adult (8 weeks) myocardial B cells (Figure 2). We combined 
10× single cell gene expression analysis with immunostaining using TotalSeq antibodies against CD11b, 
CD23, and CD21 (Supplemental Table 10). Heart B cells sorted from neonatal mice showed a distinct 
gene expression profile in comparison with B cells sorted from the adult heart (Figure 2A) and were 
mostly CD21–CD23– (Figure 2B), whereas in the adult heart, B cells were mostly CD21+CD23+ (Figure 
2B). To assess the relationship between CD21+CD23+ and CD21–CD23– cells, we performed a pseudotime 
analysis using the density of  CD21–CD23– cells to guide the pseudotime estimation. This analysis showed 
a trajectory from CD21–CD23– cells in neonatal hearts to CD21+CD23+ cells in adult hearts (Figure 2C), 
suggesting that CD21–CD23– B cells mature into CD21+CD23+ B cells. Comparison of  the genes unique-
ly upregulated in CD21–CD23– cells, CD21+CD23+ cells, and CD11b+ cells using the Immgen RNAseq 
signature database identified myocardial CD21–CD23– cells as newly formed B cells (NFB)/transitional 
1 (T1) cells (Figure 2D), myocardial CD21+CD23+ B cells as T3/follicular (FO) cells (Figure 2E), and 
CD11b+ cells as B1 cells (Figure 2F) (Supplemental Table 2). Viewed together, these analyses suggest 
that myocardial B cells are composed of  subsets of  follicular, transitional, and B1 cells, and that the ratio 
between these different subtypes of  B cells changes dynamically from embryonic life to adulthood.
We have shown previously that myocardial-associated B cells in the adult heart were primarily intravascu-
lar in location and in close approximation with vascular endothelial cells (13). To determine whether B cells 
were intravascular throughout development, we harvested hearts from CD19-Cre tdTomato reporter mice (13) 
from E18 to 5 weeks of age. Hearts were fixed and sectioned, and immunofluorescence staining was performed 
for the endothelial marker CD31. Figure 3 and Supplemental Videos 1–4 show that, in all analyzed time points, 
the vast majority of myocardial B cells were intravascular and in close association with the endothelium.
Global changes in B cells during growth and tissue-specific features. In our prior work, we showed that, in adult 
mice, myocardial B cells recirculate between the heart and spleen (13). We sought to determine whether the 
observed changes in cardiac B cell characteristics from the embryo to the adult mirrored changes in splenic B 
cells from the embryo to the adult. Figure 4, A–C, and Supplemental Table 3 show that the dynamic changes 
in B cell subsets observed in the heart paralleled changes in B cell subsets occurring in the spleen. For example, 
in neonatal stages P1–P14, the spleen had a similar increase in the prevalence of  CD19+CD11b+IgMhiCD5+ 
cells that we had observed in the heart in the first weeks of  postnatal growth. Analysis of  spleen B lympho-
cytes revealed a similar age-related decrease in the pool of  CD19+CD11b+CD21–CD23– cells that occurred 
as the pool CD19+CD11b+CD21+CD23+ cells increased, mirroring the changes observed in the neonatal and 
adult heart (Figure 4, A–C and Supplemental Table 3).
Given that the dynamic changes in B cell subsets observed in the heart reflected changes observed in 
the spleen, we next asked whether this relationship was specific for the heart and spleen, or whether it 
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Figure 1. Myocardial B cell subsets change from late embryonic life to adult-
hood. (A) Representative flow charts showing the expression of CD5 and IgM in 
CD19+CD11b+ B cells in the heart from E13.5 to 10 weeks of age. The box inserts 
within each graph delineate the positions of the IgMhiCD5+ subset and of the 
IgMhiCD5– subset. The prevalence of IgMhiCD5+ B cells increases during neonatal 
life (peak at P7), but this is not sustained during adult life. (B) Representative 
flow charts of CD21 and CD23 expression in myocardial CD19+CD11b– B cells. The 
box inserts within each graph delineate CD21–CD23– and CD21+CD23+ subsets. 
CD21–CD23– cells are the majority of B cells at birth, and their prevalence grad-
ually decreases as the prevalence of CD21+CD23+ increases. CD21+CD23+ con-
stitute the major B cell subgroup in the adult naive heart. (C) Summary graph 
showing the dynamic changes in B cell composition from embryonic to adult 
life in the heart. n = 4–7 samples. Supplemental Table 1 shows the statistical 
analysis of each subset from embryonic through adult life. From E13.5 to P7, 
3–6 embryonic and neonatal hearts were pooled together to constitute n = 1.
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reflected, more broadly, a similar relationship between splenic B cells and B cells in peripheral organs. To 
address this question, we simultaneously analyzed B cell subsets in the heart, spleen, blood, lung, and liv-
er of  neonatal and adult mice. All animals were carefully perfused with HBSS (with Ca2+ and Mg2+) after 
blood collection and before organ collection, in order to minimize the possible contamination of  periph-
eral blood B cells in the various organs (for details, see Methods). We found that the dynamic changes in 
B cell subsets observed in the heart and spleen were also observed in other peripheral organs (Figure 5A). 
This statement notwithstanding, we noticed that there were several tissue-specific features with respect to 
Figure 2. Transcriptional profiling identifies myocardial B cells as a heterogeneous, dynamic population of transitional, follicular, and B1 cells. 
(A) A 10× sequencing analysis of CD45+Aqua–CD19+ cells sorted from the heart of neonatal (2 week old) and adult (8 week old) mice. Neonatal and 
adult cardiac B cells show a distinct transcriptional profile. (B) Subsets of B cells from neonatal and adult myocardium. Cardiac B cells were stained 
with TotalSeq antibodies for CD11b, CD23, and CD21 before sequencing. Comparison of this UMAP plot with the UMAP plot reported in A shows that 
CD21+CD23+ cells are mostly found in the adult heart, while CD21–CD23– are mostly neonatal. (C) Differentially expressed genes between B cell subsets 
were used to generate hypothetical developmental relationships using Monocle algorithms. Pseudotime analysis indicates that CD21–CD23– cells move 
toward CD21+CD23+ cells. (D–F) Heatmaps reporting the relative expression of the top 20 unique upregulated genes in the CD21–CD23– (D), CD21+CD23+ 
(E), and CD11b+ (F) myocardial cells within various B cell subtypes catalogued in the Immgen RNAseq database (for details, see Supplemental Table 2). 
The transcriptional profile of CD21+CD23+ myocardial B cells resembles the transcriptional profile of splenic Transitional 3 (T3) and follicular cells (D). 
Cardiac CD21–CD23– cluster are similar to T1 and newly formed B cells (BM-NFB) (E). CD11b+ myocardial B cells are transcriptionally similar to B1 cells in 
the peritoneal cavity (F). Sp, spleen; P, peritoneal; CLP, common lymphoid progenitor; NFB, newly formed B cell; T, transitional; (F), female; FO, follicu-
lar; MZ, marginal zone; Mem, memory; GC, germinal center; CB, centroblasts; CC, centrocytes; PB, plasmasblasts; PC, plasma cells.
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B cell ontogeny. As one example, at P14, the prevalence of  CD19+CD11b+IgMhiCD5– cells was highest in 
the lung, intermediate in heart, spleen, and blood, and lowest in the liver (Figure 5B and Supplemental 
Table 4). In contrast, the prevalence of  CD19+CD11b+CD21–CD23– cells in the heart at birth (P1) was 
significantly different from that observed in blood, lung, and spleen (Figure 5B and P value in Supple-
mental Table 4). Many other tissue-specific differences were identified and are reported in Supplemental 
Table 4. Viewed together, these data show that the prevalence of  B cell subsets changes dynamically in 
the heart, spleen, blood, lung, and liver during early postnatal life and that, while there is considerable 
overlap of  the B cell subsets in different organs, there are tissue-specific features with respect to tissue- 
associated B cell subsets in the neonate and adult mouse.
Myocardial B cells represent a subset of  circulating B cells that are in close contact with the microvascular endothelium 
of  the heart and have a unique transcriptional profile. We have shown previously through histological analysis, 
intravital microscopy, and 10× single cell sequencing that intravascular myocardial B cells are distinct from 
circulating B cells and have a unique transcriptional profile (13). The findings in the present study with respect 
to the concurrent changes in B cell surface markers in the heart and spleen raised the interesting possibility that 
the subpopulations of  B cells identified in the heart might not be unique to the heart but rather might reflect 
changes in subpopulations of  B cells in close approximation with the microvasculature in different organs. To 
test this possibility, we performed histological analysis of  lung and liver, intravital microscopy of  the lung, and 
10× single cells sequencing of  B cells from the heart, blood, lung, and the liver. We first investigated the loca-
tion of  B lymphocytes histologically, by harvesting the lung and liver of  CD19-tdTomato reporter mice, and 
then performing immunofluorescence staining with an anti-CD31 antibody. Immunofluorescence analysis of  
the liver (Figure 6A and Supplemental Videos 5–7) and lung (Figure 6B and Supplemental Videos 8–10) at 
P7, P14, and 5 weeks of  age showed that the majority of  B cells in these tissues were intravascular and in close 
relationship with the endothelium in neonates and adults, consistent with our previous findings in myocardial 
tissue (13). We next performed intravital microscopy of  the lung of  CD19-tdTomato reporter mice (Figure 
6C and Supplemental Videos 11–13). We found that lung-associated B cells were predominately intravascular. 
Some B cells flowed rapidly through the vessels, while other B cells transited more slowly, and some paused 
on the endothelium, consistent with our prior intravital microscopy studies of  myocardial B cells (13). Finally, 
we performed single cell sequencing of  FACS-sorted B cells isolated from blood and perfused heart, liver, and 
lung. Samples were collected from the same mice, at the same time, and underwent the same digestion and 
staining protocols. To identify the tissue origin of  the B cells, samples were stained with Hashtag antibodies 
(Supplemental Table 10), processed within the same 10× cDNA library, and sequenced together to eliminate 
potential “batch” artifacts. Figure 7A shows unsupervised clustering of  scRNAseq data from this experiment. 
We identified the same clusters of  B cells in blood, heart, liver, and lung. However, the relative density of  
specific clusters varied markedly between blood and organs (heart, liver, and lung), whereas the cluster density 
was similar in heart, liver, and lung. For instance, cluster 0 was abundantly represented in organ-associated 
(heart, liver, and lung) B cells but not in circulating B cells. Cluster 2 was the largest cluster in B cells from the 
blood but was rare among organ-associated B cells (Figure 7A). These data suggest that circulating blood B 
cells have a transcriptional profile that is distinct from that of  intravascular B cells associated with liver, lung, 
and heart, and suggests that myocardial-associated B cells have a transcriptional profile that is similar to that 
of  tissue-associated B cells present in other organs.
Figure 3. Myocardial-associated B cells are mostly intravascular throughout late embryonic life and early adulthood. Representative immunostained 
cryosections from the heart of CD19 reporter mice. CD19-tdTomato B cells are red, CD31+ endothelial cells green, and nuclear staining (DAPI) is blue. Heart 
samples were collected at E18.5, P7, P14, and 5 weeks of age. The majority of B cells was intravascular. Pictures of the heart were taken at the level of the 
papillary muscles (magnification 63×). Scale bars: 10 μm. Yellow arrowheads mark the location of B cells.
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Figure 4. Splenic B cell subsets change from 
late embryonic life to adulthood. (A) Repre-
sentative flow charts showing the expression 
of CD5 and IgM in CD19+CD11b+ splenic B cells 
from E18 to adult stage (10 weeks old). The 
box inserts within the charts delineate the 
IgMhiCD5+ and IgMhiCD5– subsets. The prev-
alence of IgMhiCD5+ B cells increases during 
neonatal life (peak at P7), before decreas-
ing as mice mature toward adulthood. (B) 
Representative flow charts of CD21 and CD23 
expression in splenic CD19+CD11b– B cells. 
The box inserts within each chart delineate 
the CD21–CD23–, CD21+CD23+, and CD21hiCD23– 
subsets. (C) Summary graph showing the 
dynamic changes in B cell composition from 
embryonic to adult life in the spleen. Changes 
in splenic B cell subsets mirror changes in 
myocardial B cell subsets. Supplemental 
Table 3 shows the statistical analysis of each 
subset from embryonic through adult life.  
n = 3–6 samples/condition. From E18 to P7, 
3–6 embryonic and neonatal spleens were 
pooled together to constitute n = 1.
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To confirm these findings, we first examined the expression of B cell–specific markers (Cd79a, Cd19, and 
Cd79b) in the above analysis and eliminated any cells that were negative for these markers from further analysis 
(Supplemental Figure 4). Then, we comparatively analyzed the gene expression profile of B cells from different 
compartments via heatmaps. Figure 7B shows a heatmap of the differentially expressed genes in B cells sorted 
from blood, heart, liver, and lung (Supplemental Table 5). These analyses confirmed that circulating B cells 
have a transcriptional profile distinct from that of organ-associated B cells and show that organ-associated B 
cells isolated from heart, lung, and liver have remarkable similarities. We explored the functional significance of  
the gene expression differences between blood and tissue-associated B cells using Gene Ontology (GO) Enrich-
ment Analysis (Table 1) and Kyoto Encyclopedia of Genes and Genomes (KEGG; https://www.genome.
jp/kegg) pathways analysis (Supplemental Table 6). When compared with blood B cells, tissue-associated B 
cells were characterized by a differential regulation of several GO Biological Process Pathways, including cell 
activation and regulation of immune system process (Table 1), as well as KEGG signaling pathways associated 
with B cell receptor signaling and antigen processing and presentation (Supplemental Table 6).
Finally, we performed heatmap-based analysis and functional annotation of  the genes differentially 
expressed in cluster zero, which is the cluster most represented within organ-associated B cells. Figure 7C 
Figure 5. Changes in myocardial-associated B cell subsets mirror changes in B cell subsets observed in spleen, blood, lung, and liver, despite the pres-
ence of organ-specific features. (A) Group data showing the composition B cell in the heart, spleen, blood, lung, and liver from P1 to 5 weeks of age. B 
cell composition is similar in all tissues and goes through the same dynamic changes during growth. The IgMhiCD5+ subset expands in early neonatal life, 
and the CD21–CD23– subset gradually decreases during development as the prevalence of the CD21+CD23+ subset increases. (B) Summary data showing 
the contribution of each B cell subset across tissues at different time points during growth. Despite marked similarities, tissue-specific features are 
present at various time points. Supplemental Table 4 shows the statistical analysis of each tissue and subset. n = 4–6 samples/condition. At P1, tissues 
from 3–4 animals were pooled together to constitute n = 1.
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shows that cluster 0 had a transcriptional profile clearly distinct from that of  the other 6 clusters (Supplemen-
tal Table 7). Table 2 and Supplemental Table 8 show that cells in cluster zero were characterized by GO Bio-
logical Process Pathways related to B cell activation and metabolic activation (Table 2) and KEGG signaling 
pathways (Supplemental Table 8) associated with B cell receptor signaling and oxidative phosphorylation. 
These findings support the point of  view that myocardial-associated B cells are a subset of  a larger pool of  
intravascular organ-associated B cells that are transcriptionally distinct from circulating blood B cells and 
are characterized by activation of  transcriptional pathways consistent with cell activation, increased metab-
olism, B cell receptor signaling, and possibly antigen processing and presentation.
Discussion
In the present study, we systematically investigated B cell characteristics in the embryonic, neonatal, 
and adult mouse heart. We found that B cells are present in the naive heart as early as E13.5 (Figure 
1). Consistent with our prior observations in the adult heart (13), we found that naive B cells in the 
heart are predominantly intravascular throughout embryonic and neonatal life (Figure 1, Figure 2, 
and Figure 3) and that myocardial B cells are in dynamic equilibrium with splenic B cells (Figure 4 
and Figure 5). Surprisingly, we found that myocardial-associated B cells are representative of  a much 
larger, previously unappreciated population of  tissue-associated B cells (Figure 6 and Figure 7) that 
are also in equilibrium with splenic B cells. These findings broaden our understanding of  myocardial 
B cell biology and challenge the current model of  naive B cell behavior, which posits that naive B cells 
continuously recirculate between primary and secondary lymphoid organs without accumulating in 
peripheral tissue unless there is tissue injury (10–12).
The myocardial leukocyte pool changes during development of  the heart, especially within the 
monocyte/macrophage compartment (15–17). Our findings with respect to the dynamic changes of  
myocardial-associated B cells during embryonic and early postnatal development (Figure 1) expand 
Figure 6. Liver- and lung-associated B cells are mostly intravascular from neonatal to adult life. (A and B) Representative 
confocal pictures from neonatal and adult samples, showing that the majority of liver (A) and lung (B) B cells are intravascu-
lar and in association with the endothelium. CD19-tdTomato, red; CD31, green; DAPI, blue. Scale bars: 10 μm. (C) Still images 
from intravital microscopy of B cells flowing through the lung of adult mice. In the lung, B cells were found in the intravas-
cular space, circulating or pausing within the microvasculature. B cells, green; vasculature: red. Scale bars: 30 μm.
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Figure 7. Myocardial-associated B cells are part of a pool of organ-associated B cells transcriptionally distinct from circulating B cells. (A) UMAP plot of 
CD19+ cells sorted from the blood and from perfused heart, liver, and lung. B cells from different tissues were collected from the same mice. Unsupervised clus-
tering analysis reveals that all identified clusters were present in all tissues analyzed. However, the prevalence of specific clusters varied. Cluster 0 is abundant 
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upon these observations. By analyzing the expression of  CD19, CD11b, CD5, CD21, and CD23, 
we identified 4 distinct B cell subgroups within the naive murine heart, whose relative expression 
changed markedly throughout development, including CD19+CD11b+CD5+, CD19+CD11b+CD5–, 
CD19+CD11b–CD21+CD23+, and CD19+CD11b–CD21–CD23– B cells (Figure 1). The population of  
CD19+CD11b+ cells were IgMhi, which is a classic signature of  B1 cells (18). Within this subgroup, 
CD5 expression discriminates B1a cells (CD5+, only of  embryonic origin) from B1b cells (CD5–, both 
of  embryonic origin and of  BM origin) (18, 19). In contrast, CD19+CD11b– cells are strictly BM-derived 
(B2) cells (18). Our data show that the prevalence of  CD19+CD11b+ B1 cells decreases in concert with 
a reciprocal increase in the prevalence of  CD19+CD11b– B2 cells during the transition from embryonic 
to adult life (Figure 1), consistent with the embryonic origin of  B1 cells. Since B2 cells are typically BM 
derived, these findings suggests that embryonic B cells do not reside within the parenchyma, as we have 
reported for embryonic macrophages (16, 20), which are self-replicating and remain resident within 
the parenchyma of  the myocardium throughout adult life. Fate mapping studies of  CD19+CD11b– and 
CD19+CD11b+ myocardial-associated B cells will be needed to confirm these findings.
To further refine our identification of  B cell subsets based on surface markers, we performed 10× scRNA-
seq. Gene expression analysis of  the Immgen RNAseq data base (Immunological Genome Project) indicat-
ed that the CD11b+ cells were B1 cells (Figure 2F). scRNAseq analysis of  CD11b– cells revealed that the 
murine heart harbors mainly 2 subpopulations of  B2 cells. A population of  CD21–CD23– cells was detected 
as early as E15.5, it peaked on P1, and was found to be comprised of  early transitional B cells (Figure 2D). 
A population of  CD21+CD23+ cells was detectable as early as P5, peaked in the adult heart, and was found 
to be comprised mostly of  naive, T3/FO cells (Figure 2E). These findings are consistent with the observation 
that transitional B cells are immature B cells that migrate from the BM into the spleen (21), whereas T3/FO 
B cells are recirculating B cells that mature in the spleen (22). These data confirm our earlier observations 
that the majority of  myocardial B cells in the murine heart are naive follicular B cells (13). Our pseudotime 
analysis showed that the trajectory of  CD21–CD23– cells moved in direction to CD21+CD23+ cells (Fig-
ure 2C), further suggesting that CD21–CD23– cells represent immature B cells that are destined to become 
CD21+CD23+ B cells. Although pseudotime estimation is not a definitive means for determining cell fate, 
at the time of  this writing, we are unaware of  specific cell fate markers for B cells that would allow a more 
definitive analysis. Accordingly, the studies of  pseudotime estimation should be regarded as provisional.
We have shown previously that B cells in the adult heart are predominately intravascular and are 
part of  a larger population of  B cells that circulates between the heart, blood, spleen, and other organs 
(13). The observation in the present study that the age-related changes in the composition of  myocardial- 
associated B cells are mirrored by age-related changes in splenic B cells are in agreement with our pre-
vious findings and strongly suggest that B cells circulate between the heart, the blood, and the spleen in 
the embryo, neonatal, and adult mouse (Figure 4). These observations prompted us to ask whether there 
might be similar age-related changes in B cell populations in other tissue beds. To test this hypothesis, 
we first performed a flow cytometric analysis of  temporal changes in B cell populations in the blood, 
liver, lung, spleen, and heart (Figure 5). This analysis revealed that the age-related temporal changes in 
B cell subsets observed in one tissue mirrored those observed in all the other tissues that were examined 
(Figure 5). Immunofluorescence studies showed that, analogous to the heart, B cells in the lung and liver 
were almost exclusively intravascular and were in close approximation to endothelial cells (Figure 6 and 
Supplemental Videos 5–10). Intravital microscopy of  the lung revealed that circulating B cells paused in 
the lung microvasculature, mimicking a behavior that we had previously observed performing intravital 
microscopy on the heart (Figure 6 and Supplemental Videos 11–13; ref. 13).
To further explore the relationship between circulating B cells and B cells in the heart, lung, and 
liver, we simultaneously collected blood and tissue samples and performed 10× scRNAseq on each of  
these samples. Clustering analysis revealed that there were 7 unique B cell clusters in the blood, heart, 
liver, and lung; however, the number of  cells within each cluster differed depending on whether the B 
cells were freely circulating in the blood or whether the B cells were associated to tissue beds. As shown, 
the relative numbers of  cells within clusters 0–6 were similar in the heart, lung, and liver, whereas the 
in heart, liver, and lung and almost absent from circulating blood. Cluster 2 is highly prevalent in the blood and is rare in tissues. (B) Heatmap of the differen-
tially expressed genes in blood, heart, liver, and lung. Transcriptional profile of blood cells is distinct from that of organ-associated B cells. (C) Heatmap of the 
differentially expressed genes in cluster 0. B cells in cluster 0 present a characteristic transcriptional signature when compared with the other clusters.
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number of  cells in cluster 2 from blood B cells was increased relative to the number of  cells in cluster 2 
in the heart, lung, and liver (Figure 7A). Pathway analysis of  the genes that were differentially expressed 
in B cells in tissue vs. blood (Table 1 and Supplemental Table 6) revealed that B cells associated to the 
heart, liver, and lung had enrichment of  gene pathways associated with increased metabolic activity, 
active B cell receptor signaling, and active antigen presentation pathways (Table 1 and Supplemental 
Table 6). The cluster analysis also identified a specific B cell cluster that was virtually absent from the 
blood but was enriched in the heart, liver, and lung (cluster 0; Figure 7A). Functional pathway analysis 
of  genes differentially expressed within this cluster (Figure 7C) revealed that this cluster was enriched 
for genes that were associated with B cell activation, B cell receptor signaling, increased metabolic 
activity, and oxidative phosphorylation receptor (Table 2 and Supplemental Table 8). Although this 
analysis does not address the important question of  whether there are populations of  circulating B cells 
that become activated in order to adhere to vascular endothelial cells, or whether the circulating B cells 
randomly attach to the vascular endothelium where they become activated, the observation that B cells 
in cluster 0 were enriched within tissues but were virtually nonexistent in the blood suggests that circu-
lating B cells become activated once they come into close proximity to vascular endothelial cells, where 
they may play a role in immune surveillance of  membrane-bound antigens present on the endothelial 
surface. Consistent with this point of  view, our functional pathway analysis shows that the population 
of  intravascular B cells associated with tissues is characterized by activity within the B cell receptor 
signaling and antigen presentation pathways. Further studies will be needed to define the biological 
mechanism that underscores these transcriptional differences.
In summary, in the present report, we have characterized the dynamic age-related changes in naive 
myocardial B1 and B2 cells in the embryonic, neonatal, and the adult heart. Our findings show that 
Table 1. Biological Process Pathway analysis of blood B cells in comparison with organ-associated B cells
Gene set name No. of genes in gene 
get (K)
No. of genes in 
overlap (k)
k/K P value
GO_RESPONSE_TO_CYTOKINE 1192 21 0.0176 2.69 × 10–15
GO_POSITIVE_REGULATION_OF_BIOSYNTHETIC_PROCESS 1983 25 0.0126 7.01 × 10–15
GO_POSITIVE_REGULATION_OF_GENE_EXPRESSION 1974 23 0.0117 5.82 × 10–13
GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_
POLYMERASE_II
1185 18 0.0152 4.36 × 10–12
GO_POSITIVE_REGULATION_OF_RNA_BIOSYNTHETIC_PROCESS 1600 20 0.0125 7.67 × 10–12
GO_CELL_ACTIVATION 1424 19 0.0133 9.36 × 10–12
GO_LEUKOCYTE_DIFFERENTIATION 508 13 0.0256 1.05 × 10–11
GO_IMMUNE_SYSTEM_DEVELOPMENT 972 16 0.0165 2.50 × 10–11
GO_REGULATION_OF_IMMUNE_SYSTEM_PROCESS 1631 19 0.0116 9.48 × 10–11
GO_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION 1846 20 0.0108 9.83 × 10–11
Table 2. Biological Process Pathway Analysis of cluster 0 markers
Gene set name No. of genes in 
gene get (K)
No. of genes in 
overlap (k)
k/K P value
GO_RESPONSE_TO_BACTERIUM 681 13 0.0191 4.12 × 10–11
GO_RESPONSE_TO_BIOTIC_STIMULUS 1023 15 0.0147 4.30 × 10–11
GO_B_CELL_ACTIVATION 301 10 0.0332 4.39 × 10–11
GO_POSITIVE_REGULATION_OF_BIOSYNTHETIC_PROCESS 1983 18 0.0091 8.43 × 10–10
GO_LYMPHOCYTE_ACTIVATION 721 12 0.0166 1.19 × 10–9
GO_OXIDATIVE_PHOSPHORYLATION 140 7 0.05 2.57 × 10–9
GO_REGULATION_OF_IMMUNE_SYSTEM_PROCESS 1631 16 0.0098 3.02 × 10–9
GO_IMMUNE_SYSTEM_DEVELOPMENT 972 13 0.0134 3.10 × 10–9
GO_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT 96 6 0.0625 9.86 × 10–9
GO_RESPIRATORY_ELECTRON_TRANSPORT_CHAIN 115 6 0.0522 2.93 × 10–8
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the changes in subsets of  intravascular myocardial B cells are mirrored by changes in splenic B cells, 
suggesting that B cells circulate between the heart and spleen throughout life. Moreover, and to some 
extent surprisingly, our studies suggest that the temporal changes in subsets of  intravascular myocar-
dial B cells are not unique to the heart, but rather are broadly reflective of  changes in intravascular 
B cells located in other organs, such as the liver and the lung. These findings indicate that current 
models of  the dynamics of  the naive B cells are incomplete. Germane to this discussion, both our flow 
cytometric analysis and our gene expression analysis highlighted that, despite having many overlap-
ping phenotypic and transcriptional profiles, the populations of  B cells pools associated with different 
organs have unique tissue-specific features (Figure 5B, Figure 7, A and B, and Supplemental Tables 
4 and 5). The biological significance, if  any, of  these tissue-specific characteristics remains unclear at 
present; accordingly, further work will be needed to investigate the functional significance of  organ- 
associated B cells, both at baseline and in the context of  tissue injury.
Methods
Mice
To study B cell subsets during development, we used male and female C57BL/6J (stock no. 000664) mice 
between embryonic age E13.5 and early adulthood (10 weeks old). These mice, including timed-pregnant 
females, were purchased from The Jackson Laboratory. To generate a CD19 reporter model, CD19-Cre 
male mice (C57BL/6J; B6.129P2(C)-Cd19tm1(cre)Cgn/J; stock no. 006785) were bred with Rosa-tdTomato 
females (C57BL/6J; B6.Cg-Gt(ROSA)26Sortm14(CAG–TdTomato)Hze/J; stock no. 007914), as previously described 
(13). The F1 generation was employed for all the experiments. Mice were bred and maintained at the 
Washington University School of  Medicine.
Flow cytometric analysis
Isolation of  B cells from digested tissues. For flow cytometry experiments, mice were euthanized by either decap-
itation (when younger than 7 days old) or CO2 inhalation. Hearts were perfused with ~5 mL of  cold HBSS 
with Ca2+ and Mg2+. Any extracardiac tissue was removed, and hearts were finely minced. In preliminary 
experiments, we determined that tissue digestion using Collagenase type I (MilliporeSigma; catalog C0130) 
affected the expression of  the B cell surface markers CD21 and CD23, whereas the use of  purified Collage-
nase (Worthington; catalog LS005277) resulted in the preservation of  these molecules (Supplemental Figure 
1). Accordingly, hearts were digested with purified Collagenase (Worthington; catalog LS005277; 200 U/
mL), DNAse I type II (MilliporeSigma; catalog D4527; 60 U/mL), and hyaluronidase (MilliporeSigma; 
catalog H3506; 60 U/mL) in a final volume of  3 mL of  HBSS for 30 minutes at 37°C with agitation. A total 
of  6 mL of  a 2% FBS/2% BSA solution in HBSS was added to block the enzymatic activity. The digested 
sample was filtered using 40 μm cell strainers and centrifuged at 400 g for 7 minutes at 4°C. RBCs were lysed 
using ACK Lysis Buffer (Thermo Fisher Scientific; catalog A10492). The remaining cells were resuspended 
in 200 μL of  FACS Buffer (2% FBS, 2 μM EDTA in sterile PBS) and stained with conjugated antibodies 
(Supplemental Table 6) for 30–45 minutes at 4°C and washed with FACS Buffer before analysis. Embryonic 
hearts were dissected under a binocular microscope and pooled in groups of  3–5 hearts per tube for down-
stream analysis. Digestion of  the embryonic tissue was performed in 1 mL of  HBSS containing purified Col-
lagenase (Worthington; catalog LS005277; 200 U/mL), DNAse I type II (MilliporeSigma; catalog D4527; 
60 U/mL), and hyaluronidase (MilliporeSigma; catalog H3506; 60 U/mL) for 30 minutes at 37°C with 
agitation. Supplemental Table 9 shows the antibodies used in this study. Compensation controls were gener-
ated using UltraComp ebeads (Invitrogen; catalog 01-2222-42). Positive cells were determined by the use of  
single-color control samples from heart and spleen. FMO staining was used as an additional staining con-
trol. Dead cells were excluded using the Zombie Aqua dye (BioLegend; catalog 423102). Data were acquired 
using BD LSR-Fortessa X20 analyzer at the Washington University Department of  Pathology Flow Cytom-
etry and Sorting Core facility. The gating strategy used is shown in Supplemental Figure 2 (heart).
Collection of  blood, heart, spleen, liver, and lung B cells. Trunk blood was obtained after euthanasia and 
collected into tubes containing heparin. Prior to collection of  heart, liver, and lung, animals were per-
fused as follows. The abdominal and thoracic cavities were exposed. The left kidney was removed to 
create an exit point for blood and perfusing solution. A 27–20 G needle connected with a perfusion sys-
tem containing HBSS (with Ca2+ and Mg2+) was inserted into the right ventricle. Animals were perfused 
1 3insight.jci.org   https://doi.org/10.1172/jci.insight.139377
R E S E A R C H  A R T I C L E
with 8–10 mL of  HBSS. Tissue coloration was observed, and only tissues that became pale through 
perfusion (as they were cleared of  intravascular blood) were used for further analysis. Perfused organs 
were removed and transferred to a tube containing cold HBSS. Spleens were removed and finely minced 
using 40 μm filters in HBSS. Blood, heart, spleen, liver, and lung were collected from the same mice and 
digested as described in the “Isolation of  B cells from digested tissues” section.
Cell sorting and single cell transcriptional profiling
We used the Chromium Single Cell 3′ v3 or 5′ Library Kit and Chromium instrument (both from 10x 
Genomics) to perform single cell transcriptional profiling analyses.
Neonatal and adult myocardial B cells. We performed transcriptional profiling of  cardiac B cells isolated 
from 6 neonatal (2 weeks old) and 6 adult (8 weeks old) WT mice. In this experiment, we did 3′ sequencing. 
B cells were isolated as described in the “Isolation of  B cells from digested tissues” section. Neonatal and 
adult samples were treated in exactly the same way. After removing RBCs, the remaining cells were resus-
pended in 200 μL of  FACS Buffer containing 1% of  TruStain FcX Plus (BioLegend; catalog 156604; Fc 
Blocker). A total of  2 μL of  Zombie Aqua Fixable Viability Kit (BioLegend; catalog 423102) was added to 
each sample. Neonatal samples were pooled in 2 tubes with 3 hearts/tube. Adult samples were also pooled 
in 2 tubes with 3 hearts/tube. A total of  1 μL of  CD45/PerCP-Cy5 and CD19/APC antibody (Supplemen-
tal Table 9) was added to each tube. A total of  4 μL of  CD21, CD23, and CD11b Oligo-Antibody (Supple-
mental Table 10 for details) was added to each tube. Cells were incubated for 30 minutes at 4°C protected 
from light and then washed twice with FACS Buffer. Twenty-seven thousand CD45+Aqua– CD19+ cells 
(doublets excluded) were sorted in each group using a FACS Aria-II Cell Sorter. Sorted B cells were col-
lected in PBS (0.4% BSA). CD45+Aqua–CD19+ sorted cells were centrifuged at 1000 g, 4°C for 10 minutes 
(acceleration 7 and break 0) and resuspended in 20 μL of  PBS 0.4% BSA. The neonatal and adult samples 
were submitted to the MacDonnell Genome Institute at Washington University for further processing. 
Sample processing and analyses were performed as previously described (13). Neonatal and adult B cells 
were digested and sorted following the same experimental conditions and on the same day. B cell identity 
in CD21+CD23+, CD21–CD23–, and CD11b+ groups was determined by comparing the upregulated genes 
in each subset to known RNAseq databases provided by the Immunological Genome Project (Immgen, 
http://rstats.immgen.org/MyGeneSet_New/index.html). The data are available on NCIB GEO reposito-
ry accession number GSE153568 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE153568).
Heart, blood, lung, and liver. To compare the gene expression profile of  heart, blood, lung, and liver, we 
used adult WT mice at 10 weeks of  age. In this experiment, we performed 5′ sequencing. Heart, blood, 
lung, and liver were isolated from the same mice. Digestion and staining protocols were described in 
“Neonatal and Adult B cells”. We collected 5000 blood B cells, 5000 lung B cells, 5000 liver B cells, and 
5000 heart B cells. They were all labeled with Hashtag-C antibodies. Blood was labeled with Hashtag-C 
#1, lung with Hashtag-C #2, liver with Hashtag-C #3, and heart with Hashtag-C #4 (See Supplemental 
Table 10 for antibody details). Blood, heart, lung, and liver were submitted to the same digestion protocol, 
and B cells were sorted on the same day. Gene expression analysis was performed only in cells that were 
positive for B cell markers (see Supplemental Figure 4 for details). Pathway analysis of  genes differentially 
expressed in blood, heart, lung, and liver B cells was performed using the GSEA software (MSigDB ver-
sion 7.0) (23, 24). GO Enrichment Analysis and KEGG pathway analysis were used. Only pathways relat-
ed to signal transduction, immune system, and energy metabolism were used in KEGG pathway analysis. 
The data are available on NCIB GEO repository accession number GSE153569 (https://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE153569).
scRNAseq bioinformatics
Single cell expression data were processed using Cell Ranger Single Cell Software Suite v3.1.0 for sample 
demultiplexing, alignment, filtering, UMI counting, and data aggregation (https://support.10xgenomics.com/
single-cell-gene-expression/software/pipelines/latest/what-is-cell-ranger). Differential expression analyses were 
preformed using R package Seurat (25). Pseudotime analyses were preformed using R Package Monocle 3 (26).
CD31 staining in the heart, lung, and liver of CD19 reporter mice
Hearts, lung, and liver from CD19 reporter mice were perfused with HBSS as described in “Collection of  
blood, heart, spleen, liver, and lung B cells”. Tissues were fixed in 3.7% formalin for 24 hours at 4°C and then 
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transferred to 30% sucrose for 24 hours before embedding in OCT and flash freezing. Sections (10 μm) were 
blocked with a solution 2% FCS and 2% blocking reagent (Roche; catalog 11 096 176 001) in maleate buffer 
(100 mM Maleic Acid, 150 mM NaCl, pH 7.5) for 1 hour at room temperature. Sections were stained with the 
primary antibody for anti-CD31 (R&D Systems; catalog AF3628; 1:15), overnight at 4°C, followed by incuba-
tion with NL637 secondary antibody (R&D Systems; catalog NL002; 1:200) for 4 hours at room temperature. 
DAPI was used as a nuclear counterstain. Slides were imaged using a Zeiss LSM 880 Confocal microscope 
(63× magnification for objective lenses) at the Washington University Center for Cellular Imaging (WUCCI). 
Pictures of  the heart were taken at the level of  the papillary muscles (63× magnification for objective lenses).
Intravital microscopy
Intravital imaging of  the lung of  adult B6 CD19-tdTomato mice was performed using a custom-built 2-pho-
ton microscope running ImageWarp version 2.1 software (A&B Software) as described previously (13). 
Time-lapse imaging of  lymphocyte trafficking in the lung was performed by averaging 15 video-rate frames 
(0.5 seconds per slice) captured during the acquisition to match the ventilator rate and minimize movement 
artifacts. Each plane represents an image measuring 220–240 μm in the x and y dimensions. Twenty-one 
sequential planes were acquired in the z dimension (2.5 μm each) and compiled to generate a Z-stack. Blood 
vessels were visualized by i.v. injection of  50 μL of  PBS containing 20 μL of  655-nm nontargeted Q-dots.
Statistics
All results are presented as mean ± SEM. Statistical comparisons were performed using 2-way ANOVA 
followed by Tukey’s post hoc test. Data were analyzed with GraphPad Prism Version 8.
Study approval
All studies were performed with the approval of  the IACUC at Washington University School of  Medi-
cine. These investigations conform to the Guide for the Care and Use of  Laboratory Animals (National Acade-
mies Press, 2011). Experiments were performed according to protocols approved by the IACUC at Wash-
ington University School of  Medicine.
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